Most Recent
Construction PRO
Iplex fails to keep NZ parent out of builder’s defects case
Fletcher Building Group unit Iplex has lost its bid to save its parent company from being joined to a case brought by builder J-Corp over allegedly defective pipes.
Slater & Gordon can’t duck ex-HR exec’s suit over email with salary data
Slater & Gordon has lost its bid to summarily dismiss a negligence suit by a former human resources executive who claims she was wrongfully accused of sending a firm-wide email containing sensitive salary data.
Construction PRO
High Court to hear IGA spat with Victorian planning minister
The High Court has taken up an appeal by the Victorian planning minister in a row with IGA that seeks guidance on the jurisdictional reach of the state Supreme Court in planning disputes.
Construction PRO
No permit for ‘bulky’ development on East Melbourne vacant lot
VCAT has upheld a local council's refusal of a plan to build a three-storey luxury apartment building at a vacant lot in East Melbourne, saying it would "visually dominate" a neighbouring heritage-listed home.
Construction PRO
Geocon wins appeal over excess GST on $115M property sales
Canberra developer Geocon has won a Full Court appeal over the GST payable on $115 million in sales from a 360-unit development, with the case sent back to a tribunal for final determination.
Construction PRO
Timber company loses fight with Valuer-General over $110M forest
Grand Ridge Plantations has lost an appeal seeking to halve the official valuation of its Gippsland timber forest, with a court finding that the trees on the land must be included in its assessed value.
Slater & Gordon settles suit by former HR head
Slater & Gordon has settled a lawsuit by its former HR head alleging she was axed after expressing concerns that the firm deliberately underpaid over $300,000 in leave entitlements.
Regeneron, Bayer settle appeal over launch of Sandoz’s Eylea biosimilar
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea. 
Fortescue, Element Zero reach settlement in trade secrets case
After losing a fight over access to millions of seized documents, Fortescue has settled its trade secrets case against green iron company Element Zero.
Chief Justice raises concerns about ‘very personal’ recusal bid
The Chief Justice of the Federal Court has raised concerns about reallocating a case by a self-represented litigant whose recusal bid became “very personal”, with photos of the judge, his family and a sick family member filed as evidence.